Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease
- PMID: 27002796
- PMCID: PMC4860097
- DOI: 10.1038/ajg.2016.57
Gestational Diabetes Mellitus Is Strongly Associated With Non-Alcoholic Fatty Liver Disease
Abstract
Objectives: Insulin resistance is central to the development of non-alcoholic fatty liver disease (NAFLD), and gestational diabetes mellitus (GDM) is an early marker of insulin resistance. We hypothesized that a history of GDM would identify women at higher risk of NAFLD in middle age.
Methods: Women from the multicenter Coronary Artery Risk Development in Young Adults (CARDIA) cohort study who delivered ≥1 birth, were free of diabetes prior to pregnancy(ies), and underwent CT quantification of hepatic steatosis 25 years following cohort entry (Y25: 2010-2011) were included (n=1,115). History of GDM by self-report, validated in a subsample by review of antenatal glucose testing, and metabolic risk factors were assessed prospectively. NAFLD was defined by liver attenuation (LA)≤40 Hounsfield Units on CT scan after exclusion of other causes of hepatic steatosis.
Results: Of 1,115 women meeting selection criteria (57% black, 43% white, median age 25 years at baseline), 124 (11%) reported a history of GDM and 75 (7%) met the CT definition for NAFLD at year 25. The crude risk of NAFLD at the 25-year visit was significantly higher in women with GDM compared to those without (14 vs. 5.8%, OR: 2.56, 95% CI: 1.44-4.55, P<0.01). History of GDM remained associated with NAFLD (OR: 2.29, 95% CI: 1.23-4.27, P=0.01) after adjustment for covariates in multivariable logistic regression. Addition of incident diabetes mellitus (DM) into the final model attenuated the association between GDM and NAFLD (OR: 1.48, 95% CI: 0.73-3.02, P=0.28).
Conclusion: GDM is a risk marker for NAFLD and represents an opportunity to identify women at risk for NAFLD at a young age and may be mediated by the development of incident DM.
Figures


References
-
- Williams CD, Stengel J, Asike MI, et al. Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study. Gastroenterology. 2011;140:124–31. - PubMed
-
- Charlton MR, Burns JM, Pedersen RA, Watt KD, Heimbach JK, Dierkhising RA. Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States. Gastroenterology. 2011;141:1249–53. - PubMed
-
- Baffy G, Brunt EM, Caldwell SH. Hepatocellular carcinoma in non-alcoholic fatty liver disease: an emerging menace. Journal of hepatology. 2012;56:1384–91. - PubMed
-
- Herrera E. Metabolic adaptations in pregnancy and their implications for the availability of substrates to the fetus. European journal of clinical nutrition. 2000;54(Suppl 1):S47–51. - PubMed
Publication types
MeSH terms
Grants and funding
- R01 DK090047/DK/NIDDK NIH HHS/United States
- HHSN268201300026C/HL/NHLBI NIH HHS/United States
- P30 DK026743/DK/NIDDK NIH HHS/United States
- R01 DK106201/DK/NIDDK NIH HHS/United States
- P30 DK079626/DK/NIDDK NIH HHS/United States
- HHSN268201300025C/HL/NHLBI NIH HHS/United States
- T32 DK060414/DK/NIDDK NIH HHS/United States
- HHSN268201300027C/HL/NHLBI NIH HHS/United States
- R01 HL098445/HL/NHLBI NIH HHS/United States
- HHSN268201300029C/HL/NHLBI NIH HHS/United States
- K01 DK059944/DK/NIDDK NIH HHS/United States
- UL1 TR001422/TR/NCATS NIH HHS/United States
- HHSN268200900041C/HL/NHLBI NIH HHS/United States
- HHSN268201300028C/HL/NHLBI NIH HHS/United States
- KL2 TR001424/TR/NCATS NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous